Patient info Open main menu

Oxycodone Molteni 50 mg/ml solution for injection or infusion – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Controlled drug (Schedule 2) Details

Medicine strength:
50 mg/ml
Contains active substance:
ATC code:

Patient leaflet - Oxycodone Molteni 50 mg/ml solution for injection or infusion

1. What Oxycodone is and what it is used for

The full name of your injection is

Oxycodone injection. In this leaflet the

shorter name ‘Oxycodone’ is used. It

contains the active ingredient oxycodone

hydrochloride. This belongs to a group

of medicines called pain-killers (or

‘analgesics’).

Oxycodone is used for moderate to severe

pain.

2. What you need to know before you use Oxycodone

Do not use Oxycodone if:

  • you are allergic to oxycodone

    hydrochloride or any of the other

    ingredients of the injection (listed in

    section 6)

  • you have breathing problems, such

    as ‘severe chronic obstructive lung

    disease’, ‘severe bronchial asthma’ or

    ‘severe respiratory depression’ where

    you feel breathless, with coughing or

    breathing more slowly or weakly

  • you have a problem where you have

    severe pain in your tummy or part of your

    gut does not work properly (‘paralytic

    ileus of your small bowel’)

  • you have a heart problem caused by

    long-term lung disease (‘cor pulmonale’)

  • you have moderate to severe liver

    problems

  • you are often constipated
  • you are under 18 years of age.

Do not use Oxycodone if any of the above

apply to you. If you are not sure, talk to

your doctor, pharmacist or nurse before

using Oxycodone.

Warning and precautions

Talk to your doctor, pharmacist or nurse before using this injection if:

  • you are elderly or weakened
  • you have an under-active thyroid gland (‘hypo-thyroidism’) – you may need a lower dose
  • you have myxoedema (a thyroid disorder with dryness, coldness and swelling [‘puffiness’] of the skin affecting the face and limbs;
  • you have a head injury, a severe headache or feel sick – this may be a sign of high pressure in your skull
  • you have low blood volume

    (hypovolaemia); this can happen with severe external or internal bleeding, severe burns, excessive sweating, severe diarrhoea or vomiting;you have low blood pressure (‘hypo-tension’)

  • you have a mental problem caused by an infection (‘toxic psychosis’)
  • you have problems with your gall bladder or bile duct
  • you have inflammation of the pancreas (which causes severe pain in the abdomen and back)
  • you have inflammatory bowel disease
  • you have prostate problems
  • you feel weak or dizzy, feel sick or be sick or have weight loss – these may be signs that your adrenal gland is not working properly
  • you have breathing problems such as in ‘severe lung disease’ where you feel breathless with coughing
  • you have previously suffered from withdrawal symptoms such as feeling agitated or anxious, shaking or sweating when stopping taking alcohol or drugs

  • you have kidney problems
  • you have liver problems

If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before using Oxycodone. Contact your doctor if you experience severe upper abdominal pain possibly radiating to the back, nausea, vomiting or fever as this could be symptoms associated with inflammation of the pancreas (pancreatitis) and the biliary tract system. Tolerance, dependence and addiction

This medicine contains oxycodone, which is an opioid. It can cause dependence and/or addiction.

This medicine contains oxycodone which is an opioid medicine. Repeated use of opioid painkillers can result in the drug being less effective (you become accustomed to it, known as tolerance). Repeated use of Oxycodone may lead to dependence, abuse, and addiction, which may result in life-threatening overdose. The risk of these side effects can increase with a higher dose and longer duration of use. Dependence or addiction can make you feel that you are no longer in control of how much medicine you need to take or how often you need to take it. You might feel that you need to carry on taking your medicine, even when it doesn’t help to relieve your pain.

Pag 1 Pag 4

Common: may affect up to 1 in 10 people

  • dry mouth, loss of appetite, indigestion,

    tummy pain or discomfort, diarrhoea

  • confusion, depression, feeling weak,

    shaking, lack of energy, tiredness,

    anxious or nervous, difficulty sleeping,

    unusual thoughts or dreams

  • difficulty breathing or wheezing, feeling

    short of breath, not being able to cough

    properly

  • rash
  • sweating.

Uncommon: may affect up to 1 in 100

people

  • allergic reactions
  • difficulty breathing
  • fast, uneven heart beat, flushing
  • spinning feeling
  • seeing or hearing things that are not

    real (hallucination), mood changes, ,

    unpleasant or uncomfortable mood,

    feeling of extreme happiness, feeling

    restless, agitated or generally unwell,

    loss of memory

  • difficulty speaking, reduced sensitivity to

    pain or touch , tingling or numbness in

    the hands or feet, fits, visual impairment,

    fainting, unusual muscle stiffness

    or slackness, involuntary muscle

    contractions

  • dry skin, severe flaking or peeling of the

    skin

  • dehydration, feeling thirsty, chills,

    swelling of the hands, ankles or feet

  • redness of the face, smaller pupils in the

    eye, muscle spasm, high temperature

  • difficulty swallowing, burping, hiccups,

    wind, a condition where the bowel

    does not work properly (ileus), stomach

    problems, changes in the way things taste,

  • difficulty passing urine, problems getting

    an erection, decreased sexual drive,

    low levels of sex hormones in the blood

    (‘hypogonadism’, seen in a blood test)

  • needing to take higher doses of the

    medicine than normal to get the same

    amount of pain relief (tolerance) – as with

    all strong pain-killers, there is a risk that

    you may become addicted or tolerant to

    this injection withdrawal symptoms (see

    section 2 “Warnings and precautions”)

  • changes to liver test results, biliary colic.

Rare side effects: may affect up to 1 in

1000 people

  • low blood pressure,
  • feeling faint especially when standing up
  • hives (nettle rash).

Frequency not known: frequency cannot

be estimated from the available data

  • an increased sensitivity to pain
  • aggression
  • tooth decay
  • lack of menstrual periods
  • a blockage in the flow of bile from the

    liver (cholestasis). This can cause itchy

    skin, yellow skin, very dark urine and

    very pale stools

  • a problem affecting a valve in the

    intestines that may cause severe upper

    abdominal pain (sphincter of Oddi

    dysfunction)

  • Long term use of Oxycodone during

    pregnancy may cause life-threatening

    withdrawal symptoms in the newborn.

    Symptoms to look for in the baby include

    irritability, hyperactivity and abnormal sleep

    pattern, high pitched cry, shaking, being

    sick, diarrhoea and not putting on weight

    slow and shallow breathing (respiratory

    depression) or withdrawal symptoms in

    the newborn baby.

    If you are pregnant or breast-feeding, think

    you may be pregnant or are planning to

    have a baby, ask your doctor or pharmacist

    for advice before using this injection.

    Breast-feeding

    Do not breast-feed while using

    Oxycodone. This is because the medicine

    may pass into breast milk.

    Driving and using machines

    You may feel sleepy or have other side

    effects like feeling weak, dizzy or faint

    while using Oxycodone. These are more

    likely at the start of treatment or when

    changing to a higher dose. If this happens,

    do not drive or use any tools or machines.

    Oxycodone contains sodium

    Oxycodone 50 mg/ml – 1 ml ampoule

    contains less than 1 mmol sodium (23 mg)

    per ampoule, that is to say essentially

    ‘sodium-free’.

3. How to use Oxycodone

Before starting treatment and regularly

during treatment, your doctor will discuss

with you what you may expect from using

Oxycodone, when and how long you need

to take it, when to contact your doctor,

and when you need to stop it (see also if

you stop using Oxycodone).

Oxycodone is normally given by a doctor

or nurse. The injection should be used

straight away after opening.

Having this medicine

The injection can be given in 3 ways;

  • into a vein over 1 to 2 minutes
  • through a needle under the skin
  • as a ‘drip’ (infusion).

How much to use

Your doctor will work out the right dose for

you. The dose and how often the injection

is given may be changed depending on

your level of pain.

The usual starting dose depends on how

the injection is given – your doctor will work

this out. The usual starting doses are:

  • single injection into a vein – usually 1 to

    10 mg given slowly over 1 to 2 minutes.

    Doses will be given at least 4 hours apart

  • single injection through a fine needle

    into the tissue under the skin – the

    recommended starting dose is 5 mg

    usually given every 4 hours.

As a ‘drip’ (also called an infusion):

  • an infusion into a vein – usual starting

    dose is 2 mg each hour

  • an infusion through a fine needle into

    the tissue under the skin – usual starting

    dose is 7.5 mg per day

  • an infusion controlled by you (‘patient

    controlled analgesia’ or ‘PCA’) – the dose

    depends on your weight (0.03 mg per kg of

    body weight). Your doctor or nurse will work

    out how often you need the medicine.

If you are still in pain whilst using Oxycodone

talk to your doctor, pharmacist or nurse.

Children and young people

Do not use this injection if you are under

18 years of age.

People with kidney or liver problems

Talk to your doctor, pharmacist or nurse

if you have any kidney or liver problems.

This is because they may give you a

different medicine or a lower dose of

Oxycodone.

If you use more Oxycodone than you should, or if someone else uses your injection

Do not use more Oxycodone than the doctor tells you to. Check with your doctor or pharmacist if you are not sure. If you think you have had too much of the medicine (‘overdose’), talk to your doctor or go to hospital straight away. Take the medicine pack with you. Do not drive or do anything that needs you to be alert. The following effects may happen if you use too much of this medicine:

  • smaller pupils in the eye
  • slower or weaker breathing than normal (respiratory depression)
  • feeling sleepy or fainting
  • low muscle tone (hypotonia)
  • slower pulse rate
  • low blood pressure
  • a brain disorder (known as toxic leukoencephalopathy).

In some serious cases, an overdose may make you pass out (become ‘unconscious’) or could cause death. If you stop using Oxycodone

Do not suddenly stop using this injection unless your doctor tells you to.

If you want to stop using your injection, talk to your doctor first. They will tell you how to do this. This is usually by reducing the dose slowly, so you do not get side effects. The following may happen if you suddenly stop using this injection:

  • feeling agitated or anxious
  • palpitations
  • shaking
  • sweating.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this injection can cause side effects, although not everybody gets them.

Serious side effects

Stop using Oxycodone and tell your doctor straight away if you notice any of the following serious side effects:

  • allergic reactions – the signs may include suddenly feeling wheezy, difficulty breathing, swelling of the eyelids, face or lips, rash or itching – these may cover your whole body
  • breathing problems – the signs may include breathing more slowly or weakly. Stop using Oxycodone and tell your doctor straight away if you notice any of the serious side effects above.

Other side effects

Tell your doctor, pharmacist or nurse if you notice any of the following side effects: Very common: may affect more than 1 in 10 people

  • constipation – your doctor can give you medicines to help with this
  • feeling or being sick – this should normally wear off after a few days. If it does not wear off, your doctor can give you medicines to help with this
  • feeling sleepy – this is most likely when you start using your injection or when your dose is increased, but it should wear off after a few days
  • headache
  • dizziness
  • itchy skin

    Pag 3

Pag 2

The risk of becoming dependent or

addicted varies from person to person.

You may have a greater risk of becoming

dependent or addicted on Oxycodone if:

  • You or anyone in your family have ever

    abused or been dependent on alcohol,

    prescription medicines or illegal drugs

    (“addiction”)

  • You are a smoker
  • You have ever had problems with your

    mood (depression, anxiety or a personality

    disorder) or have been treated by a

    psychiatrist for other mental illnesses.

If you notice any of the following signs

whilst taking Oxycodone, it could be a

sign that you have become dependent or

addicted.

  • You need to take the medicine for longer

    than advised by your doctor

  • You need to take more than the

    recommended dose

  • You are using the medicine for reasons

    other than prescribed, for instance, ‘to

    stay calm’ or ‘help you sleep’

  • You have made repeated, unsuccessful

    attempts to quit or control the use of the

    medicine

  • When you stop taking the medicine you

    feel unwell, and you feel better once

    taking the medicine again (‘withdrawal

    effects’)

If you notice any of these signs, speak to

your doctor to discuss the best treatment

pathway for you, including when it is

appropriate to stop and how to stop

safely (See section 3, If you stop using

Oxycodone).

Sleep-related breathing disorders

Oxycodone can cause sleep-related

breathing disorders such as sleep apnoea

(breathing pauses during sleep) and sleep

related hypoxemia (low oxygen level in

the blood). The symptoms can include

breathing pauses during sleep, night

awakening due to shortness of breath,

difficulties to maintain sleep or excessive

drowsiness during the day. If you or

another person observe these symptoms,

contact your doctor. A dose reduction may

be considered by your doctor.

Children and young people

Do not use this injection if you are under

18 years of age.

Other medicines and Oxycodone

Tell your doctor or pharmacist if you are

taking, have recently taken or might take

any other medicines, including herbal

medicines. This is because Oxycodone

can affect the way some other medicines

work. Also some other medicines can

affect the way Oxycodone works.

Concomitant use of Oxycodone

and sedative medicines such as

benzodiazepines or related drugs

increases the risk of drowsiness,

difficulties in breathing (respiratory

depression), coma and may be

life-threatening. Because of this,

concomitant use should only be

considered when other treatment options

are not possible. However if your doctor

does prescribe Oxycodone together

with sedative medicines the dose and

duration of concomitant treatment should

be limited by your doctor. Please tell

your doctor about all sedative medicines

you are taking, and follow your doctor’s

dose recommendation closely. It could

be helpful to inform friends or relatives

to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.

The risk of side effects increases, if you use antidepressants (such as citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine). These medicines may interact with oxycodone and you may experience symptoms such as involuntary, rhythmic contractions of muscles, including the muscles that control movement of the eye, agitation, excessive sweating, tremor, exaggeration of reflexes, increased muscle tension, body temperature above 38°C. Contact your doctor when experiencing such symptoms.

Do not use this medicine and tell your doctor or pharmacist if you are taking

  • a type of medicine known as a

    ‘monoamine oxidase inhibitor’, such as tranylcypromide, phenelzine, isocarboxazid, moclobemide and linezolid. Tell your doctor or pharmacist if you are taking any of the following:

  • a type of medicine known as a monoamine oxidase inhibitor or you have taken this type of medicine in the last two weeks;
  • medicines to help you sleep, such as tranquillisers, hypnotics or sedatives including benzodiazepines
  • medicines for depression
  • medicines for mental health problems, such as phenothiazines or neuroleptics
  • other strong pain-killers or ‘analgesics’
  • medicines which relax your muscles
  • medicines for high blood pressure
  • medicines for infections, such as clarithromycin, erythromycin or telithromycin
  • medicines for fungal infections, such as ketoconazole, voriconazole, itraconazole or posaconazole
  • a type of medicine for HIV called ‘protease inhibitors’, such as boceprevir, ritonavir, indinavir, nelfinavir or saquinavir
  • rifampicin (to treat tuberculosis);
  • carbamazepine (a medicine to treat sezures, fits or convulsions and certain pain conditions);
  • phenytoin (a medicine to treat seizures, fits or convulsions);
  • cimetidine, used for stomach ulcers, indigestion or heartburn
  • quinidine, used for a fast heart beat
  • anaesthetics, used before an operation or medical procedure
  • a herbal remedy called St. John’s Wort (also known as Hypericum perforatum)
  • antihistamines
  • medicines to treat Parkinson’s disease If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before using Oxycodone.

Oxycodone with food, drink and alcohol

  • Do not drink grapefruit juice while you are being treated with Oxycodone.
  • Do not drink alcohol while you are being treated with Oxycodone. This is because it may make you feel sleepy or increase the risk of serious side effects such as shallow breathing with a risk of stopping breathing, and loss of consciousness. Pregnancy and breast-feeding Pregnancy

Do not use this injection if you are pregnant unless your doctor has said it is okay. It should also not be used during labour. This is because it may cause

  • s.c. (Bolus): Dilute in 0.9% saline, 5% dextrose or water for injections. A starting dose of 5 mg is recommended at 4-hourly intervals as required for opioid-naïve patients.
  • s.c. (infusion): Dilute in 0.9% saline, 5% dextrose or water for injections if required. A starting dose of 7.5 mg/day is recommended in opioid naïve patients, titrating gradually according to symptom control. Cancer patients transferring from oral oxycodone may require much higher doses (see below).

Transferring patients between oral and parenteral oxycodone: The dose should be based on the following ratio: 2 mg of oral oxycodone is equivalent to 1 mg of parenteral oxycodone. It must be emphasised that this is a guide to the dose required. Inter-patient variability requires that each patient is carefully titrated to the appropriate dose.

Elderly:

Elderly patients should be treated with caution. The lowest dose should be administered with careful titration to pain control.

Patients with renal or hepatic impairment:

The dose initiation should follow a conservative approach in these patients. The recommended adult starting dose should be reduced by 50% (for example a total daily dose of 10 mg orally in opioid naïve patients), and each patient should be titrated to adequate pain control according to their clinical situation. Pediatric population:

There are no data on the use of Oxycodone injection in patients under 18 years of age.

Use in non-malignant pain:

Opioids are not first-line therapy for chronic non-malignant pain, nor are they recommended as the only treatment. Types of chronic pain which have been shown to be alleviated by strong opioids include chronic osteoarthritic pain and intervertebral disc disease.

Method of administration

Subcutaneous injection or infusion.

Intravenous injection or infusion.

Treatment goals and discontinuation

Before initiating treatment with Oxycodone, a treatment strategy including treatment duration and treatment goals, and a plan for end of the treatment, should be agreed together with the patient, in accordance with pain management guidelines. During treatment, there should be frequent contact between the physician and the patient to evaluate the need for continued treatment, consider discontinuation and to adjust dosages if needed. When a patient no longer requires therapy with oxycodone, it may be advisable to taper the dose gradually to prevent symptoms of withdrawal. In absence of adequate pain control, the possibility of hyperalgesia, tolerance and progression of underlying disease should be considered (see section 4.4 of the summary of product characteristics).

Duration of treatment:

Oxycodone should not be used for longer than necessary.

✂

  • Sleep apnoea (breathing pauses during sleep).

Tell your doctor, pharmacist or nurse if you notice any of the side effects listed above. Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not

listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Oxycodone

Keep this injection out of sight and reach of children. Store this medicine in a locked safe and secure storage space, where other people cannot access it. It can cause serious harm and be fatal to people when it has not been prescribed for them. Do not use this injection after the expiry date, which is stated on the ampoule label and carton after ‘Exp.’

This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from light. Once the ampoule is opened the injection should be used immediately. Any unused medicine should be discarded immediately.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Oxycodone contains

  • The active ingredient is oxycodone hydrochloride.
  • The other ingredients are: citric acid monohydrate, sodium citrate, sodium chloride, hydrochloric acid dilute, sodium hydroxide, water for injections.

What Oxycodone looks like and the contents of the pack

This injection is a clear, colourless solution supplied in clear glass ampoules. The 50 mg/ml strength is available as 1 ml of solution (containing 50 mg of oxycodone hydrochloride).

Marketing Authorisation Holder and Manufacturer

L. Molteni & C. dei F.lli Alitti

Società di Esercizio SpA -

Strada Statale 67, Fraz. Granatieri - 50018 Scandicci (Firenze) – Italy

Tel: +3905573611

Fax: +39055720057

e-mail: info@moltenifarma.it

This medicinal product is authorised in the Member States of the EEA under the following names:

Oxycodone Medac France Ossicodone Molteni Italy Oxycodone Molteni Poland

This leaflet was last revised in 02/2025

Information for Health Professionals

Oxycodone 50 mg/ml, solution for injection or infusion

Oxycodone hydrochloride

Posology and method of administration

Posology:

The dose should be adjusted according to the severity of pain, the total condition of the patient and previous or concurrent medication.

Adults over 18 years:

The following starting doses are recommended for opioid-naïve patients. The initial dose should be adjusted to previous or concurrent medication (especially if the patient has been treated with other opioids before), the total condition of the patient, and the severity of pain. A gradual increase in dose may be required if analgesia is inadequate or if pain severity increases.

  • i.v. (bolus): Dilute in 0.9% saline, 5% dextrose or water for injections. Administer a bolus dose of 1 to 10 mg slowly over 1-2 minutes in opioid-naïve patients. Doses should not be administered more frequently than every 4 hours.
  • i.v. (infusion): Dilute in 0.9% saline, 5% dextrose or water for injections. A starting dose of 2 mg/hour is recommended for opioid-naïve patients.
  • i.v. (PCA): Dilute in 0.9% saline, 5% dextrose or water for injections. Bolus doses of 0.03 mg/kg should be administered with a minimum lock-out time of 5 minutes for opioid-naïve patients.

Instruction for use/handling

Each ampoule is for single use in a single patient. The injection should be given immediately after opening the ampoule, and any unused portion should be discarded. Chemical and physical in-use stability has been demonstrated for 24 hours at 15 – 25°C room temperature.

From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution, dilution, etc. has taken place in controlled and validated aseptic conditions.

Oxycodone 50 mg/ml injection, undiluted or diluted to 3 mg/ml with 0.9% w/v saline, 5% w/v dextrose or water for injections, is physically and chemically stable when in contact with representative brands of polypropylene or polycarbonate syringes, polyethylene or PVC tubing and PVC or EVA infusion bags, over a 24 hour period at room temperature.

The 50 mg/ml injection, whether undiluted or diluted to 3 mg/ml in the infusion fluids used in these studies and contained in the various assemblies, does not need to be protected from light.

Inappropriate handling of the undiluted solution after opening of the original ampoule, or of the diluted solutions may compromise the sterility of the product. Please refer to the summary of product characteristics for other information. This leaflet was last revised in 02/2025

✂ Package leaflet: Information for the user

Oxycodone 50 mg/ml, solution for injection or infusion

Oxycodone hydrochloride

020F106018/R7

020F106018/R7

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 16046/0025

Last revision stated in the text: February 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Oxycodone Molteni 50 mg/ml solution for injection or infusion

Prescription needed? Yes, prescription-only medicine (POM)
Controlled drug
Yes, Schedule 2 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules, schedule 5 the lightest.
  • Schedule 2 is the strictest group of prescribed medicines, for example strong opioid painkillers and medicines for ADHD.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. It cannot be issued as a repeat dispensing prescription.
  • When you collect it, the pharmacist must check whether you are the patient and may ask for ID.
  • Travelling abroad: you can usually carry up to 3 months' supply. Take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to (GOV.UK).
  • Never give it to anyone else.
Active substance Oxycodone
Strength 50 mg/ml
Pharmaceutical form Solution for injection
A clear, colourless solution with a pH between 4.5-5.5.
The osmolality is between 267-310 mOsm/Kg.
How is it taken Subcutaneous, Intravenous
Excipients Citric acid monohydrate, Sodium citrate, Sodium chloride, Hydrochloric acid, dilute (for pH adjustment), Sodium hydroxide (for pH adjustment), Water for injections
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months unopened.
After opening use immediately.
For further information, see section 6.6.
Storage This medicinal product does not require any special temperature storage conditions. Store in the original package in order to protect from light.
For further information on use after opening, see section 6.6.
Drug group (ATC) Natural opium alkaloid, opioid, analgesics
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AA Natural opium alkaloid analgesics
          1. N02AA05 oxycodone
Marketing authorisation PL 16046/0025 (first authorised 12 January 2024)
Marketing authorisation holder L. Molteni & C. dei F.lli Alitti Società di Esercizio SpA - Strada Statale 67, Fraz. Granatieri – 50018 Scandicci (Firenze) – Italy
Codes BNF 04070200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.